9/12
11:28 am
algs
Aligos Therapeutics (NASDAQ:ALGS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Aligos Therapeutics (NASDAQ:ALGS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.